confirmatory-trial-negative
No description yet: the sentence for this tag has not been written. 1 record carries it: 1 treatment.
1 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Enasidenib Idhifa Enasidenib is the IDH2 counterpart of ivosidenib, approved in the US for relapsed disease but never approved in Europe after it failed to extend survival in a confirmatory trial. | Approved2017🇺🇸 | Acute myeloid leukaemia, IDH1- and IDH2-mutated acute myeloid leukaemia, Sinonasal undifferentiated carcinoma (SNUC) and SWI/SNF-deficient sinonasal carcinoma | none |